Apheresis Equipment Market Report by Product, Application, Procedure, Technology, End User, and Region 2024-2032
2023년 전 세계 혈액성분채집 장비 시장 규모는 26억 달러에 달했습니다. 향후 IMARC 그룹은 2024-2032년간 8%의 연평균 성장률(CAGR)을 보이며 2032년까지 54억 달러에 달할 것으로 예상하고 있습니다.
원심분리 또는 막여과를 통해 세포, 혈장, 혈소판, 백혈구 등 혈액에서 특정 성분을 제거하기 위해 사용되는 것이 바로 혈액성분채집 장비입니다. 남은 혈액 성분은 기증자나 환자의 혈류에 다시 도입됩니다. 혈액은행과 다양한 병증 치료에 적용되고 있습니다. 최근에는 최신 혈액성분채집 장비의 채용으로 자동 용출, 유체역학 등 첨단 기능이 개발되어 혈소판과 적혈구(RBC)의 농축 채취가 가능해졌습니다.
코로나 바이러스 감염증(코로나19)이 확산되고 효과적인 백신과 치료제가 없는 상황에서 회복기 혈장 요법이 중증 환자의 치료법으로 떠오르고 있습니다. 이 치료법은 완전히 회복된 환자의 회복기 혈장(CP)을 채취해 항체 공급원으로 활동 중인 환자에게 수혈하기 위해 혈액성분채집 장비를 활용하고 있습니다. 이 외에도 만성질환 및 신경질환의 유병률 증가, 헌혈자 수 증가도 시장 성장에 기여하고 있습니다. 또한, 양호한 상환 정책과 의료 인프라의 개선은 전 세계적으로 수혈 장비의 판매를 촉진하고 있습니다. 이 외에도 자동화된 인터페이스 시스템, 화면 탐색, 그래픽 사용자 인터페이스 디스플레이를 갖춘 첨단 변형의 채택, 연구 개발(R&D) 활동에 대한 투자 증가 등이 향후 몇 년동안 시장 전망을 밝게 해줄 것으로 예상됩니다.
본 보고서에서 다룬 주요 질문들
- 세계 혈액성분채집 장비 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 발전해 나갈 것인가?
- 코로나19는 세계 혈액성분채집 장비 시장에 어떤 영향을 미쳤을까?
- 주요 지역 시장은?
- 제품별 시장 분석은?
- 용도별 시장 분석은?
- 시술별 시장 분석은?
- 기술별 시장 현황은?
- 최종사용자별 시장 분석은?
- 산업 가치사슬의 다양한 단계는?
- 업계의 주요 촉진요인과 과제는?
- 세계 혈액성분채집 장비 시장의 구조와 주요 진출 기업은?
- 업계의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 혈액성분채집 장비 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 제품별
제7장 시장 분석 : 용도별
제8장 시장 분석 : 시술별
- 혈장 교환
- 혈소판 제거 요법
- 적혈구 제거 요법
- 백혈구 제거 요법
- 광선 요법
- 기타
제9장 시장 분석 : 기술별
제10장 시장 분석 : 최종사용자별
제11장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제12장 SWOT 분석
제13장 밸류체인 분석
제14장 Porter의 Five Forces 분석
- 개요
- 바이어의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 진출업체의 위협
- 대체품의 위협
제15장 가격 분석
제16장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 개요
- Asahi Kasei Corporation
- B. Braun Melsungen Aktiengesellschaft
- Baxter International Inc.
- Fresenius Kabi Aktiengesellschaft(Fresenius SE & Co. KGaA)
- Haemonetics Corporation
- Hemacare Corporation(Charles River Laboratories, Inc.)
- Kaneka Corporation
- Kawasumi Laboratories Inc.
- Medica SpA
- Nikkiso Co Ltd.
- Terumo BCT Inc.(Terumo Corporation)
LSH
The global apheresis equipment market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2032, exhibiting a growth rate (CAGR) of 8% during 2024-2032.
Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced into the bloodstream of the donor or patient. It finds application in blood banks and the treatment of various medical conditions. In recent years, the introduction of modern apheresis equipment has led to the development of advanced features, such as auto elutriation and fluid flow dynamics, and has enabled the collection of platelets or red blood cells (RBCs) concentrates.
Due to the spread of the coronavirus disease (COVID-19) and lack of an effective vaccine or treatment, convalescent plasma therapy is emerging as a measure for treating critically ill patients. Apheresis equipment is utilized in this therapy to collect convalescent plasma (CP) from fully recovered patients and transfuse it to active patients as a source of antibodies. Besides this, the growing prevalence of chronic diseases and neurological disorders, along with the rising number of blood donors, is also contributing to the market growth. Moreover, favorable reimbursement policies, coupled with improving healthcare infrastructure, are also driving the sales of apheresis equipment around the world. Other factors, such as the introduction of advanced variants with automated interface systems, screen navigation and graphical user interface displays, along with the increasing investments in research and development (R&D) activities, are expected to create a positive outlook for the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global apheresis equipment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application, procedure, technology and end user.
Breakup by Product:
Disposable Apheresis Kits
Apheresis Machine
Breakup by Application:
Blood Collection
Treatment
Neurology
Hematology
Renal Diseases
Others
Breakup by Procedure:
Plasmapherasis
Plateletpherasis
Erythrocytapheresis
Leukapheresis
Photopheresis
Others
Breakup by Technology:
Membrane Filtration
Centrifugation
Breakup by End User:
Blood Collection Centers
Hospitals and Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Corporation, B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA), Haemonetics Corporation, Hemacare Corporation (Charles River Laboratories Inc.), Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, Nikkiso Co Ltd. and Terumo BCT Inc. (Terumo Corporation).
Key Questions Answered in This Report:
- How has the global apheresis equipment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global apheresis equipment market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the procedure?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global apheresis equipment market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Apheresis Equipment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Disposable Apheresis Kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Apheresis Machine
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Blood Collection
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Treatment
- 7.2.1 Market Trends
- 7.2.2 Major Types
- 7.2.2.1 Neurology
- 7.2.2.2 Hematology
- 7.2.2.3 Renal Diseases
- 7.2.2.4 Others
- 7.2.3 Market Forecast
8 Market Breakup by Procedure
- 8.1 Plasmapherasis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Plateletpherasis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Erythrocytapheresis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Leukapheresis
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Photopheresis
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Technology
- 9.1 Membrane Filtration
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Centrifugation
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by End User
- 10.1 Blood Collection Centers
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Hospitals and Clinics
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.2 Asia Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Asahi Kasei Corporation
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 B. Braun Melsungen Aktiengesellschaft
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 SWOT Analysis
- 16.3.3 Baxter International Inc.
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.3.4 SWOT Analysis
- 16.3.4 Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 SWOT Analysis
- 16.3.5 Haemonetics Corporation
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 Hemacare Corporation (Charles River Laboratories, Inc.)
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.7 Kaneka Corporation
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 Kawasumi Laboratories Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.9 Medica SpA
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.10 Nikkiso Co Ltd.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 Terumo BCT Inc. (Terumo Corporation)
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 SWOT Analysis
